General Information
Version
06
Revision date
2023-07-14
Product name
HEMOSIL RINSE SOLUTION
1.2.1 Relevant identified uses
For in vitro diagnostic use
Manufacturer Name
Instrumentation Laboratory Co
Emergency telephone
+44 (0) 3700 492 795, +1 215 207 0061
Icons in SDS
Company Information
company name
Instrumentation Laboratory Co
e-mail address of the competent person responsible for the Safety Data Sheet
infosds@werfen.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
May cause an allergic skin reaction Under normal conditions of use, the mixture does not cause adverse effects to the environment. Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet
Hazard pictograms
GHS07
Signal word
Warning
Contains
2-Methyl-4-isothiazolin-3-one hydrochloride (MIT HCl)
Hazard statements
H317 - May cause an allergic skin reaction.
Precautionary statements
P272 - Contaminated work clothing should not be allowed out of the workplace. P280 - Wear protective clothing, protective gloves. P302+P352 - IF ON SKIN: Wash with plenty of water. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Skin sensitisation, Category 1 H317 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause an allergic skin reaction. Under normal conditions of use, the mixture does not cause adverse effects to the environment. Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : GHS07 Signal word (CLP) : Warning Contains : 2-Methyl-4-isothiazolin-3-one hydrochloride (MIT HCl) Hazard statements (CLP) : H317 - May cause an allergic skin reaction. Precautionary statements (CLP) : P272 - Contaminated work clothing should not be allowed out of the workplace. P280 - Wear protective clothing, protective gloves. P302+P352 - IF ON SKIN: Wash with plenty of water. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation. 2.3. Other hazards This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % SECTION 3: Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures Comments : Composition: liquid containing organic and inorganic components. Name Product identifier Conc. % Classification according to Regulation w/w (EC) No. 1272/2008 [CLP] 2-Methyl-4-isothiazolin-3-one hydrochloride (MIT HCl) CAS-No.: 26172-54-3 <0,005 Acute Tox. 3 (Oral), H301 (ATE=175 mg/kg EC-No.: 247-499-3 bodyweight) Acute Tox. 3 (Dermal), H311 (ATE=242 mg/kg bodyweight) Acute Tox. 2 (Inhalation), H330 Skin Corr. 1B, H314 Eye Dam. 1, H318 Skin Sens. 1A, H317 Aquatic Acute 1, H400 (M=10) Aquatic Chronic 1, H410 (M=1) Specific concentration limits